Numans Health Food Holdings publishes 2025 annual report

PUBT·05/21/2026 08:32:55

Listen to the news

Numans Health Food Holdings’ annual report flagged a difficult FY2025 marked by weaker demand in China’s maternal and infant nutrition market, sharper price competition in algal oil DHA, weaker ordering from a key online distributor early in the year.
Management pointed to a recovery in ordering activity from that distributor in the second half, with the commercial relationship continuing into 2026.
Strategy shifted toward portfolio expansion, including development of a new product line for children aged 6 to 16.
Product and channel plans also include pushing into lower-tier China markets with competitively priced algal oil DHA using imported raw materials from France.
A final dividend of HK$ 0.025 per share was recommended, payable on or about July 10, 2026, subject to shareholder approval on June 15, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Numans Health Food Holdings Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260521-12166287), on May 21, 2026, and is solely responsible for the information contained therein.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English